» Authors » G S Murphy

G S Murphy

Explore the profile of G S Murphy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 724
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Murphy G, Kopman A
Br J Anaesth . 2018 Jul; 121(2):335-337. PMID: 30032868
No abstract available.
2.
Murphy G, Szokol J, Avram M, Greenberg S, Shear T, Vender J, et al.
Br J Anaesth . 2014 May; 113(4):618-27. PMID: 24860157
Background: Surgery in the beach chair position (BCP) may reduce cerebral blood flow and oxygenation, resulting in neurological injuries. The authors tested the hypothesis that a ventilation strategy designed to...
3.
Murphy G, Echeverria P
Curr Opin Gastroenterol . 2006 Oct; 15(1):90-4. PMID: 17023924
During the past year, we have seen the continuing spread of antimicrobial drug resistance in important gastrointestinal pathogens. Typhoid fever seen in the United States was multidrug resistant, but still...
4.
Murphy G
Minerva Anestesiol . 2006 Feb; 72(3):97-109. PMID: 16493386
The residual effects of neuromuscular blocking agents may persist into the early postoperative recovery period, even when neuromuscular blockade is carefully monitored and reversed in the operating room. Recent data...
5.
Raviprakash K, Marques E, EWING D, Lu Y, Phillips I, PORTER K, et al.
Virology . 2002 Mar; 290(1):74-82. PMID: 11883007
We have previously shown that a dengue virus type 1 DNA vaccine expressing premembrane (prM) and envelope (E) genes was immunogenic in mice and monkeys and that rhesus monkeys vaccinated...
6.
Murphy G, Vender J
Crit Care Clin . 2002 Jan; 17(4):925-42. PMID: 11762268
The use of NMB agents for more than 24 to 48 hours in critically ill patients is associated with many potential complications. Neuromuscular-blocking drugs should be used only when their...
7.
Simmons M, Murphy G, Kochel T, Raviprakash K, Hayes C
Am J Trop Med Hyg . 2001 Nov; 65(5):420-6. PMID: 11716093
A dengue-2 (DEN-2) DNA vaccine coding for the premembrane and envelope (E) proteins and a recombinant fusion protein containing the B domain of the DEN-2 E protein fused to the...
8.
Simmons M, Murphy G, Hayes C
Am J Trop Med Hyg . 2001 Aug; 65(2):159-61. PMID: 11508393
Recombinant proteins containing the B domain of dengue virus serotypes 1-4 fused to the maltose binding protein (MBP) of Escherichia coli were evaluated individually and as a tetravalent vaccine candidate...
9.
Wu S, Lee E, Putvatana R, Shurtliff R, PORTER K, Suharyono W, et al.
J Clin Microbiol . 2001 Jul; 39(8):2794-8. PMID: 11473994
Faster techniques are needed for the early diagnosis of dengue fever and dengue hemorrhagic fever during the acute viremic phase of infection. An isothermal nucleic acid sequence-based amplification (NASBA) assay...
10.
Murphy G, Szokol J, Curran R, Votapka T, Vender J
J Cardiothorac Vasc Anesth . 2001 Jun; 15(3):336-40. PMID: 11426365
Objective: To investigate the effect of a single, vital capacity breath (vital capacity maneuver [VCM]), administered at the end of cardiopulmonary bypass (CPB), on pulmonary gas exchange in patients undergoing...